Pharma & CROs — the TransCelerate members driving DDF药企与 CRO — 推动 DDF 的 TransCelerate 成员
DDF is sponsor-driven. These ~20 big-pharma members fund it and push USDM/digital-protocol adoption into supplier requirements — i.e., AuroraPrime's target buyers.
DDF 由药企主导。这约 20 家大型药企成员出资并把 USDM / 数字方案的采用写进供应商要求——正是 AuroraPrime 的目标买家。
TransCelerate members
TransCelerate 成员
Big-pharma sponsors/adopters
大型药企赞助/采用方
On-stage adopters
登台采用方
Shared adoption view at showcase
在 showcase 分享采用视角
Our buyers
我们的买家
Quality / CMC / clinical-data leaders
质量 / CMC / 临床数据负责人
Standard mandated
被推动的标准
Into supplier requirements
写入供应商要求
TransCelerate member companiesTransCelerate 成员公司
These ~20 TransCelerate members collectively fund DDF and are moving USDM/digital-protocol adoption into their supplier requirements — i.e., the buyers who will favor USDM-native, regulatory-grade authoring tools.这约 20 家 TransCelerate 成员共同资助 DDF，并正把 USDM / 数字方案的采用写进对供应商的要求——也就是会青睐「USDM 原生 + 监管级撰写」工具的买家。
Membership is public and may shift year to year.成员名单为公开信息，可能逐年微调。
Sponsors on stage登台的药企采用方
Member companies that presented an adoption/end-user perspective (not as vendors).
以采用方 / 最终用户视角（非 vendor）登台的成员公司。
Novo Nordisk
Dec 2024 DDF Solution Showcase2024 年 12 月 DDF Solution Showcase
Sponsor adoption perspective alongside vendor Risklick — signals member companies actively piloting DDF.与 vendor Risklick 同场分享采用方视角——显示成员公司正积极试点 DDF。
Source: TransCelerate BioPharma membership (public) + DDF Solution Showcase recordings (2026-07).数据来源：TransCelerate BioPharma 公开成员名单 + DDF Solution Showcase 录像（2026-07）。